Nil Markus, Schäfer Daniela, Radtke Thomas, Saner Hugo, Wilhelm Matthias, Eser Prisca
Preventive Cardiology & Sports Medicine, University Clinic for Cardiology, Inselspital, University Hospital, Bern, Switzerland; Exercise Physiology, Institute for Human Movement Sciences, ETH Zurich, Zurich, Switzerland.
Eur J Clin Invest. 2014 Nov;44(11):1065-71. doi: 10.1111/eci.12341.
Assessment of endothelial function of the microvasculature by peripheral arterial tonometry (EndoPAT(®)) has gained increasing popularity in patients with cardiovascular risk factors. Only limited knowledge about its reproducibility in patients with coronary artery disease (CAD) is available. We therefore aimed to quantify reproducibility of EndoPAT(®) parameters in patients with stable CAD.
EndoPAT(®) measurements were performed repeatedly in 78 male patients (age 66 ± 8 years) with CAD on stable medication. We calculated overall mean, standard deviation (SD), coefficient of variation (CV) and intraclass correlation coefficient (ICC) of the following parameters: reactive hyperemic index (RHI), PAT ratio of the postocclusion period 90-150 s as used for calculation of the RHI (PAT ratio90-150 s) and 90-120 s (PAT ratio90-120 s) as used for the often employed Framingham RHI (F-RHI), as well as PAT ratio of the peak hyperemic response (PAT ratiopeak response). Additionally, least significant changes (LSC) for individual subjects and minimum sample sizes for parallel and cross-over design studies were calculated.
Mean RHI was 1·84 (SD 0·36). For RHI, PAT ratio90-150 s , PAT ratio90-120 s , and PAT ratiopeak response the CVs were 17·0%, 25·4%, 26·1%, and 25·0%, respectively. The ICCs were 0·45, 0·49, 0·48 and 0·51, respectively, and LSC for RHI was 47·2%.
CV of RHI in our population was moderate; however, we consider this precision insufficient to monitor changes in individual patients, as they would need to exceed 47% to show a significant change. Further, the poor ICCs reflect the difficulty of detecting treatment effects in homogenous populations, such as patients with stable CAD.
通过外周动脉张力测定法(EndoPAT(®))评估微血管内皮功能在有心血管危险因素的患者中越来越受欢迎。关于其在冠状动脉疾病(CAD)患者中的可重复性的知识有限。因此,我们旨在量化稳定CAD患者中EndoPAT(®)参数的可重复性。
对78名服用稳定药物的CAD男性患者(年龄66±8岁)重复进行EndoPAT(®)测量。我们计算了以下参数的总体均值、标准差(SD)、变异系数(CV)和组内相关系数(ICC):反应性充血指数(RHI)、用于计算RHI的闭塞后90 - 150秒的PAT比值(PAT ratio90 - 150 s)和用于常用的弗雷明汉RHI(F - RHI)的90 - 120秒的PAT比值(PAT ratio90 - 120 s),以及充血反应峰值的PAT比值(PAT ratiopeak response)。此外,还计算了个体受试者的最小显著变化(LSC)以及平行和交叉设计研究的最小样本量。
平均RHI为1.84(SD 0.36)。对于RHI、PAT ratio90 - 150 s、PAT ratio90 - 120 s和PAT ratiopeak response,CV分别为17.0%、25.4%、26.1%和25.0%。ICC分别为0.45、0.49、0.48和0.51,RHI的LSC为47.2%。
我们人群中RHI的CV为中等;然而,我们认为这种精度不足以监测个体患者的变化,因为个体变化需要超过[此处原文有误,应为47.2%]才能显示出显著变化。此外,较差的ICC反映了在同质人群(如稳定CAD患者)中检测治疗效果的困难。